Biocryst Pharmaceuticals Inc (BCRX): SCHEDULE 13G filed Aug 7, 2026

Form type

SCHEDULE 13G

Filing date

Aug 7, 2026

Accession number

0000093751-26-000420

Filer

Biocryst Pharmaceuticals Inc (CIK 882796)